RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 89 filers reported holding RECRO PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,281,139 | -20.1% | 1,076,587 | 0.0% | 0.03% | -52.9% |
| Q4 2022 | $1,604,115 | -8.6% | 1,076,587 | 0.0% | 0.07% | -20.5% |
| Q3 2022 | $1,755,000 | +105.0% | 1,076,587 | 0.0% | 0.09% | +95.6% |
| Q2 2022 | $856,000 | -55.8% | 1,076,587 | 0.0% | 0.04% | -35.7% |
| Q1 2022 | $1,938,000 | +5.3% | 1,076,587 | 0.0% | 0.07% | -19.5% |
| Q4 2021 | $1,841,000 | -17.0% | 1,076,587 | 0.0% | 0.09% | +40.3% |
| Q3 2021 | $2,218,000 | -10.8% | 1,076,587 | 0.0% | 0.06% | -60.5% |
| Q2 2021 | $2,487,000 | -17.2% | 1,076,587 | 0.0% | 0.16% | -10.3% |
| Q1 2021 | $3,004,000 | -2.1% | 1,076,587 | 0.0% | 0.18% | -22.2% |
| Q4 2020 | $3,068,000 | +35.7% | 1,076,587 | 0.0% | 0.22% | +6.6% |
| Q3 2020 | $2,261,000 | -53.8% | 1,076,587 | 0.0% | 0.21% | -62.6% |
| Q2 2020 | $4,898,000 | – | 1,076,587 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |